| Autor: |
Daniel Greer, Astha Parikh, Humberto R. Jimenez |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Community mental health journal. |
| ISSN: |
1573-2789 |
| Popis: |
Antipsychotic medications are used to treat many psychiatric conditions and are paramount for relapse prevention in patients with mental illnesses. Antipsychotic monotherapy (APM) is a commonly recommended approach, however there is no clear consensus on the use of antipsychotic polypharmacy (APP). A single-center retrospective review was conducted comparing readmission rates of behavioral health patients discharged on APP or APM between August 1st 2019 and July 31st 2021. The primary outcome was the one-year psychiatric readmission rate. Secondary outcomes included further readmission time frame stratification, olanzapine equivalent doses, and use of anticholinergic medications. The total readmission rate was 24.5% (24/98) in the APP group compared to 19.1% (107/560) in the APM group (p = 0.22). Patients discharged on APM were not found to have a statistically significant increase in readmission rate compared to patients discharged on APP. Further research is needed to assess the risks and benefits of APP. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink